Relay Therapeutics, Inc. (RLAY) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 1.45B |
| Enterprise Value | 1.4B |
| P/E Ratio | -11.01 |
| PEG Ratio | -0.29 |
| Price/Sales Ratio | 283.25 |
| Price/Book Ratio | 4.84 |
| Enterprise/Revenue | 267.05 |
| Enterprise/EBITDA | -10.43 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
Profitability
| Profit Margin | -25.54 |
| Operating Margin | -27.77 |
AD
Management Effectiveness
| Return On Assets | -0.39 |
| Return On Equity | -0.44 |
Income Statement
| Revenue | 15.36M |
| Revenue/Share | 0.06 |
| Gross Profit | 11.8M |
| EBITDA | -272.92M |
| Net Income | -276.48M |
| Diluted EPS | -1.61 |
Balance Sheet
| Total Cash | 642.07M |
| Total Cash/Share | 3.57 |
| Total Debt | 31.57M |
| Total Debt/Equity | 0.05 |
| Current Ratio | 22.13 |
| Book Value Per Share | 3.57 |
Price History
| 52-Week Change | 434.98 |
| 52-Week High | 17.47 |
| 52-Week Low | 3.03 |
| Moving Average 50 Days | 14.17 |
| Moving Average 200 Days | 9.31 |
Statistics
| Average Volume | 3.88M |
| Shares Outstanding | 175.02M |
| % Held by Institutions | 106.73 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
AD
